Cytyc to sell bonds to pay for Novacept:
This article was originally published in Clinica
Executive Summary
Cervical cancer screening group Cytyc plans to sell $220m of convertible notes to help fund its $311m net cash purchase of Novacept. The Boxborough, Massachusetts-based company plans to sell the notes to qualified institutional buyers, and to grant the initial purchasers an option to buy up to $30m in additional notes. Cytyc announced its intention to acquire Novacept, which makes the NovaSure device to treat menorrhagia, earlier this month (see Clinica No 1098, p 13). It had said it would fund the deal through cash in hand and a bank financing.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.